RIG
VRTX icon

Ramiah Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Ramiah Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-969
Closed -$433K – 92
2026
Q1 		$433K Sell
969
-75
-7% -$35K 2.89% 13
2025
Q4 		$473K Buy
1,044
+74
+8% +$31.9K 0.41% 43
2025
Q3 		$380K Buy
970
+77
+9% +$32.2K 0.34% 51
2025
Q2 		$398K Sell
893
-254
-22% -$117K 0.43% 49
2025
Q1 		$556K Buy
1,147
+96
+9% +$44.7K 0.53% 21
2024
Q4 		$423K Buy
1,051
+19
+2% +$8.81K 0.39% 50
2024
Q3 		$480K Sell
1,032
-728
-41% -$350K 0.45% 47
2024
Q2 		$825K Buy
1,760
+72
+4% +$31.3K 0.81% 22
2024
Q1 		$706K Sell
1,688
-173
-9% -$73.1K 0.66% 38
2023
Q4 		$757K Sell
1,861
-360
-16% -$133K 0.71% 31
2023
Q3 		$772K Sell
2,221
-564
-20% -$197K 0.8% 24
2023
Q2 		$980K Sell
2,785
-574
-17% -$193K 0.96% 23
2023
Q1 		$1.06M Buy
3,359
+305
+10% +$91.5K 0.96% 24
2022
Q4 		$882K Buy
3,054
+129
+4% +$39.3K 4.75% 5
2022
Q3 		$847K Sell
2,925
-218
-7% -$62.7K 5.12% 4
2022
Q2 		$886K Sell
3,143
-1,130
-26% -$302K 0.72% 19
2022
Q1 		$1.12M Sell
4,273
-705
-14% -$167K 0.77% 14
2021
Q4 		$1.09M Buy
4,978
+1,452
+41% +$282K 0.74% 15
2021
Q3 		$640K Buy
3,526
+92
+3% +$18K 0.46% 54
2021
Q2 		$692K Buy
3,434
+22
+0.6% +$4.6K 0.5% 48
2021
Q1 		$733K Buy
+3,412
New +$749K 0.55% 44
2020
Q3 		– Sell
-4,182
Closed -$1.21M – 89
2020
Q2 		$1.21M Buy
4,182
+2,031
+94% +$551K 1.28% 17
2020
Q1 		$512K Buy
+2,151
New +$493K 0.91% 21

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Ramiah Investment Group's VRTX Position: Q2 2026 in Review

Ramiah Investment Group sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 969 shares — an estimated $433K sold.

Ramiah Investment Group first reported a position in VRTX in Q1 2020 and held it in 23 quarters. The position peaked at $1.21M in Q2 2020. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Ramiah Investment Group reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Ramiah Investment Group sold 969 Vertex Pharmaceuticals shares in Q2 2026, an estimated $433K.
  • Ramiah Investment Group first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 23 quarters.
  • Ramiah Investment Group's Vertex Pharmaceuticals position peaked at $1.21M in Q2 2020.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.